TCL Archive NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research May 14, 1993
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds August 31, 2001
TCL Archive National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM. November 5, 2004